Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries | Ca-A Cancer Journal for Clinicians | 2018 | 41.6K |
Cancer statistics, 2018 | Ca-A Cancer Journal for Clinicians | 2018 | 12K |
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline | Journal of Clinical Oncology | 2018 | 1.7K |
Ovarian cancer statistics, 2018 | Ca-A Cancer Journal for Clinicians | 2018 | 1.3K |
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy | Cancer Discovery | 2018 | 1.3K |
Inflammatory responses and inflammation-associated diseases in organs | Oncotarget | 2018 | 1.3K |
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018 | European Journal of Cancer | 2018 | 1.1K |
Tumour heterogeneity and resistance to cancer therapies | Nature Reviews Clinical Oncology | 2018 | 1.1K |
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial | Lancet Oncology, The | 2018 | 1.1K |
Chimeric antigen receptor T-cell therapy - assessment and management of toxicities | Nature Reviews Clinical Oncology | 2018 | 1.1K |
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015 | Neuro-Oncology | 2018 | 1K |
Targeting the IL-6/JAK/STAT3 signalling axis in cancer | Nature Reviews Clinical Oncology | 2018 | 975 |
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer | Journal of Clinical Oncology | 2018 | 938 |
Artificial intelligence in radiology | Nature Reviews Cancer | 2018 | 916 |
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2018 | 897 |
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis | JAMA Oncology | 2018 | 893 |
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study | JAMA Oncology | 2018 | 875 |
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial | JAMA Oncology | 2018 | 834 |
Non-coding RNA networks in cancer | Nature Reviews Cancer | 2018 | 806 |
Circular RNAs in cancer: opportunities and challenges in the field | Oncogene | 2018 | 794 |
The Impact of Dietary Fiber on Gut Microbiota in Host Health and Disease | Cell Host and Microbe | 2018 | 786 |
Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society | Ca-A Cancer Journal for Clinicians | 2018 | 759 |
Molecular therapies and precision medicine for hepatocellular carcinoma | Nature Reviews Clinical Oncology | 2018 | 735 |
Revisiting the role of ABC transporters in multidrug-resistant cancer | Nature Reviews Cancer | 2018 | 732 |
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy | Lancet Oncology, The | 2018 | 730 |